mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.2 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.066 |
0.2 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.2 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |